Plasma Natriuretic Peptides for Community Screening for Left Ventricular Hypertrophy and Systolic Dysfunction: The Framingham Heart Study

Vasan, Ramachandran S., Benjamin, Emelia J., Larson, Martin G., Leip, Eric P., Wang, Thomas J., Wilson, Peter W. F., Levy, Daniel·2002·JAMA
DOI 10.1001/jama.288.10.1252

Cited by (493)

Items 401–493 of 493

  1. Cardiac Function
    Fred S. Apple, Jens Peter Goetze, Allan S. Jaffe · 2012 · Elsevier eBooks
  2. Review on natriuretic peptides: where we are, where we are going
    Kevin W. Jiang, Kevin Shah, Lori B. Daniels, Alan S. Maisel · 2008 · Expert Opinion on Medical Diagnostics
  3. Estudio de marcadores bioquímicos de interés en el diagnóstico y pronóstico del síndrome coronario agudo
    Aránzazu Martín García · 2011
  4. Péptido natriurético ventricular tipo B
    Jordi Forteza-Rey, Ana García Raja · 2003 · Medicina Clínica
  5. Recent advances in the diagnosis of heart failure
    James O’Neill, David O. Taylor · 2004 · Current Cardiology Reports
  6. B-type natriuretic peptide is an independent predictor for cardiovascular death in patients with no clinical signs of ventricular dysfunction after acute myocardial infarction
    Yanzhou Zhang, Lexin Wang · 2006 · Medical Hypotheses
  7. Brain natriuretic peptide: A marker for subclinical cardiovascular disease?
    David G. Gardner · 2003 · The American Journal of Medicine
  8. Novel Strategies for the Detection of Systolic and Diastolic Heart Failure
    Cara Lodewijks-van der Bolt, Leo H. B. Baur, Jelle Stoffers, Timo Lenderink, Ron A. G. Winkens · 2009 · Current Cardiology Reviews
  9. Bio-Molecular Markers for Cardiovascular Disease: Significance of Natriuretic Peptides and Adrenomedullin
    Takeshi Horio, Yuhei Kawano · 2008 · Korean Circulation Journal
  10. Neurohormonal Activation in Populations Susceptible to Heart Failure
    Johan Ärnlöv, Ramachandran Srini Vasan · 2005 · Heart Failure Clinics
  11. The Endocrine Heart: B-type Natriuretic Peptide as a Diagnostic and Therapeutic Agent in Cardiovascular Disease
    Brian D. Le, Tayo A. Addo, James A. de Lemos · 2003 · The Endocrinologist
  12. Modern Understanding in the Causes and Prevention of Heart Failure
    Qingchun Zeng, Qiong Zhan, Sijie Jiang, Dingli Xu · 2025 · Cardiology Discovery
  13. Development and validation of a novel machine learning–based algorithm to predict incident atrial fibrillation: A multicohort analysis
    Matthew W. Segar, Neil Keshvani, Byron C. Jaeger, Anna Rosenblatt, Mehdi Razavi, Mohammad Saeed, Carlos J. Rodríguez, Sadiya S. Khan, David Peter Kao, Ambarish Pandey · 2025 · Heart Rhythm
  14. ABCD's of Heart Failure: Echo-ing through the First Stage
    James N. Kirkpatrick · 2010 · Journal of the American Society of Echocardiography
  15. BNP—Considering a Heartfelt Message
    Ken A. Sikaris · 2004 · Heart Lung and Circulation
  16. ACCF/AHA Practice Guideline
    Clyde W. Yancy, Mariell L Jessup, Biykem Bozkurt, Javed Butler, Mark H. Drazner, Gregg C. Fonarow, Stephen A. Geraci, Tamara B. Horwich, James L. Januzzi, Maryl R. Johnson et al. · 2013
  17. Brain natriuretic peptide
    Theresa A. McDonagh · 2003 · CRC Press eBooks
  18. Combined Therapy with Rosiglitazone, Rofecoxib and Celecoxib Enhances Cardiovascular Side Effects through Cytochrome P450 Pathway of Arachidonic Acid Metabolism in Diabetic Arthritis Model Rats
    Xuya Zhou, Ying Liu, Deqin Xu, Jie Bao, Yaru Cao, Yong Jie Jin · 2020 · Pakistan Journal of Zoology
  19. PERSPECTIVAS EMERGENTES SOBRE O PAPEL DOS HORMÔNIOS CARDÍACOS NA DOENÇA CARDIOVASCULAR
    Antonio Peretti de Luna Freire Neto, Camila Lara de la Barrera, Gabriella Assink de Castro, Guilherme Marcos Levy Lamella, Hemerson Casado Gama, Leonardo Giglio Dragone, Rízia Kérem Gonçalves Martiniano, Robson Amaro do Nascimento Xisto, Rodney de Oliveira · 2024 · EPITAYA eBooks
  20. Distribution characteristics and screening reference values of NT-proBNP in high cardiovascular risk population
    Pingfeng Feng, Junlong Qin, Zhixin Chai, Dong Wei, Yajie Zhang, Peiyun Wang, Minghai Zhao, Bingbing He, Zhongyi Ling, Xin Li · 2025 · Nutrition Metabolism and Cardiovascular Diseases
  21. Clinical Considerations and Applications in Cardiac Diseases
    Aldo Clerico, Claudio Passino, Michele Emdin · 2007 · Springer eBooks
  22. Biosynthesis, physiology and main diagnostic and therapeutic potentials of cardiac natriuretic peptides
    Melpomeni Ntalapascha, Zoi Daniil, Epaminondas G. Zakynthinos · 2009 · International Journal of Medicine and Medical Sciences
  23. Changes of natriuretic peptides concentration in early phase of acute myocardial infarction.
    Ekrema Mujarić, Besim Prnjavorac, Merlina Kalajdžija-Cero, Harun Šestić, Almir Rošić, Rifat Sejdinović, Sefveta Mustafić, Amila Mehmedović · 2014 · PubMed
  24. Heart rate variability parameters among acute heart failure patients in a tertiary center in Nigeria
    Adeyemi OA, Akinlade OM, Ogunmodede JA, Philip M Kolo, Ibraheem A. Katibi, Omotoso ABO · 2020 · World Journal of Advanced Research and Reviews
  25. Assessment of Dyssynchrony and Its Application
    Cheuk‐Manu Yu, Qing Zhang, Jeffrey Wing‐Hong Fung · 2007
  26. Plasma cardiac natriuretic peptide levels in screening for cardiac disease
    M. Gary Nicholls, Enyioma N. Obineche, CHRISTOPHER M. A. FRAMPTON, Mark Richards · 2004 · The American Journal of Medicine
  27. Niveles urinarios de péptido natriurético tipo B (BNP) y disfunción ventricular sistólica en pacientes con insuficiencia cardiaca
    Raquel Cortés, Miguel Rivera, Luis Martínez‐Dolz, Esther Roselló‐Lletí, María José Sancho-Tello, B. Sevilla, Manuel Portolés, Juan Cosín · 2009 · Revista Clínica Española
  28. Diastolic Dysfunction in Patients With Peripheral Arterial Disease
    Şevket Balta, Saıt Demırkol, Turgay Celık, Uğur Küçük, Hi̇lal Olgun Küçük, Fahri Gürkan Yeşil · 2013 · Angiology
  29. Abnormal laboratory results: B-type natriuretic peptide: a new diagnostic tool for congestive heart failure
    Ben D. Ewald · 2003 · Australian Prescriber
  30. diagnostic study disease in primary care: cross sectional with stable chronic obstructive pulmonary Recognising heart failure in elderly patients
    Nicolaas P. A. Zuithoff, Jan‐Willem J. Lammers, Karel G.M. Moons, Maarten Jan Cramer, E Diederick · 2006
  31. Atrial fibrillation, a difficulty in the heart failure screening with natriuretic peptides
    Paulo Bettencourt, Patrícia Lourenço · 2018 · Heart
  32. Biomarkers: Population Screening and Risk-Stratification
    I. Ratjen, Ramachandran Srini Vasan, Wolfgang Lieb · 2017 · Elsevier eBooks
  33. Clinical Use of Natriuretic Peptides for the Diagnosis and Management of Heart Failure
    Alan S. Maisel · 2006 · Humana Press eBooks
  34. Sensitive Detection of Heart-Failure Biomarkers Natriuretic Peptides Using Multi-Photon Laser Wave-Mixing Spectroscopy
    James Suprapto, William G. Tong · 2022 · SSRN Electronic Journal
  35. AI-powered Coronary Artery Calcium Scans (AI-CAC) Enables Prediction of Heart Failure and Outperforms NT-proBNP: The Multi-Ethnic Study of Atherosclerosis
    Morteza Naghavi, Anthony P. Reeves, Matthew Jay Budoff, Dong Li, Kyle C. Atlas, Chenyu Zhang, Thomas L. Atlas, Claudia I. Henschke, Christopher R. deFilippi, Daniel A Levy et al. · 2024 · medRxiv
  36. Natriuretic Peptides, Diagnostic and Prognostic Biomarkers
    Joost H.W. Rutten · 2004 · RePub (Erasmus University Rotterdam)
  37. Guías de prácticas de laboratorio clínico: Biomarcadores de síndromes coronarios agudos y falla cardíaca
    Robert H. Christenson · 2009 · Redalyc (Universidad Autónoma del Estado de México)
  38. The Effect of Cardiovascular Stress on Cognition and Mortality : Studies on B-type Natriuretic Peptide amongst the Elderly Population
    Matti Hiltunen · 2014 · Työväentutkimus Vuosikirja
  39. Role of High Molecular Weight Adiponectin in the Correlation Between Higher B-type Natriuretic Peptide Level and Accumulation of Metabolic Syndrome-Related Factors—Examination in Japanese Mass Screening
    Hiroshi Kawabe, Hiroshi Hirose, Hirokazu Yokoyama, Yumiko Wainai, Ikuo Saito · 2009 · Ningen dock : official journal of the Japanese Society of Human Dry Dock
  40. Update: Therapie der chronischen Herzinsuffizienz
    Johann Auer · 2009 · Journal für Kardiologie (Krause & Pachernegg GmbH)
  41. Heart failure in COPD
    Frans Hendrik Rutten · 2005 · Utrecht University Repository (Utrecht University)
  42. Outpatient Evaluation for Cardiovascular Diseases Using Natriuretic Peptide Testing
    Aaron Leigh Baggish, James L. Januzzi · 2007
  43. Cardiac dysfunction in the very elderly : the relevance of natriuretic peptide testing in clinical practice
    Bert Vaes · 2012 · DIAL (Catholic University of Leuven)
  44. Age and gender differences in risk factor burden, myocardial dysfunction and cardiovascular events in relation to glucose metabolism
    Margrét Leósdóttir · 2012 · Lund University Publications (Lund University)
  45. Les nouveaux marqueurs biologiques de cardiologie (peptide natriurétique de type B et troponine) : intérêt en réanimation
    S. Hours · 2004 · Réanimation
  46. Therapies for preventing heart failure
    Richard F. Wright · 2003 · Current Treatment Options in Cardiovascular Medicine
  47. B-type natriuretic peptides as powerful markers in cardiac diseases – analytical and clinical aspects / B-Typ natriuretische Peptide als aussagekräftige Marker bei kardialen Erkrankungen – analytische und klinische Aspekte
    Angelika Hammerer‐Lercher, Bernd Puschendorf, Johannes Mair · 2006 · Journal of Laboratory Medicine
  48. Integrating Optimal Use of Echocardiography and Biomarkers in Heart Disease
    Gagandeep S. Gurm, Christopher R. deFilippi · 2012 · Current Cardiovascular Imaging Reports
  49. Future studies should consider multiple predisposing conditions in predicting weaning failure from mechanical ventilation in patients after cardiac surgery
    Mehmet Aydogan, Şevket Balta, Uğur Küçük, Saıt Demırkol, Murat Ünlü, Seyfettin Gümüş · 2013 · Clinics
  50. Heart failure: from bench to bedside
    Sergio Dalla Volta · 2006 · Hot Topics in Cardiology
  51. Marcadores biológicos: ¿qué aportan los péptidos natriuréticos?
    Xavier García–Moll · 2012 · Hipertensión y Riesgo Vascular
  52. Screening for Left Ventricular Dysfunction in the Community: Ready for Prime-Time?
    Martín Cowie · 2013 · European Journal of Heart Failure
  53. Asymptomatic systolic and diastolic dysfunction in patients with risk factors referred for echocardiography. The DAVES study by the Italian Society of Cardiovascular Echography
    Scipione Carerj, Salvatore La Carrubba, Alessandro Salustri, Maria Penco, F. Antonini Canterin, Concetta Zito, Gianfranco Pasini, Giovanni Di Salvo, Antonio Pezzano, Vitantonio Di Bello · 2012 · Journal of Cardiovascular Echography
  54. Cuál es el rol del sistema neurohormonal en la insuficiencia cardíaca con fracción de eyección preservada
    Enrique Alonso · 2010 · Redalyc (Universidad Autónoma del Estado de México)
  55. THE IMPACT OF THYROID DYSFUNCTION ON CARDIOVASCULAR RISK
    Alireza M. Manuchehri · 2008 · Repository@Hull (Worktribe) (University of Hull)
  56. Pattern of antimalaria treatment and risk factors for torsades de pointes in admitted heart failure patients in Lagos-Nigeria
    Janet N. A. Ajuluchukwu, Emmanuel N. Anyika, Christiana A. Boyle · 2014 · Journal of Hospital Administration
  57. [B-type natriuretic peptide and Doppler echocardiography in the diagnosis of heart failure: alternative or complementary tools?].
    Alberto Palazzuoli, Maurizio Galderisi, Maddalena Gallotta, Susanna Sciomer, Stefano Nistri, Eustachio Agricola, Piercarlo Ballo, Simona Buralli, Antonello D’Andrea, Arcangelo D’Errico et al. · 2009 · PubMed
  58. Aging and Cardiac Magnetic Resonance: Correlation between Biomarkers and Age
    Marcelo Souto Nacif, Adriana Dias Barranhas, Alair Augusto dos Santos, Fernanda Boldrini Assunção, Diogo Costa Leandro de Oliveira, Vitor Frauches Souza, Wilter dos Santos Ker, Daniel Gama das Neves, Edson dos Santos Marchiori · 2015 · International Journal of Cardiovascular Sciences
  59. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Utilization of Cardiac Biomarker Testing in Heart Failure WRITING GROUP MEMBERS
    Gary S. Francis, David A. Morrow, Laura Kristin Newby, Christopher Paul Cannon, Robert L. Jesse, Alan B. Storrow, Robert H. Christenson, Fred S. Apple, Jan Ravkilde · 2007
  60. SIGNAL TRANSDUCTION MECHANISMS AND NUCLEAR EFFECTORS IN GENE EXPRESSION DURING HYPERTROPHY OF CARDIAC MYOCYTES
    Biocenter Oulu · 2003
  61. Utilidad de los criterios clínicos para la detección de la disfunción sistólica y diastólica, comparados con el ecocardiograma y las concentraciones de NT-proBNP
    José Fidel Baizabal‐Carvallo, Lilia Castillo‐Martínez, Arturo Orea Tejeda, Victoria Valles Sánchez, Rafael Toledo, Enrique Asensio Lafuente, Verónica Rebollar González, Dora Corzo León, Joel Dorantes Garcı́a, René Narváez David · 2005 · Medicina Interna de México
  62. Service line forecasting: predicting the growth (or decline) of a hospital's inpatient services.
    H Menkin · 1991 · PubMed
  63. Signal transduction mechanisms and nuclear effectors in gene expression during hypertrophy of cardiac myocytes
    Sampsa Pikkarainen · 2003
  64. Disease Prevention in Heart Failure
    Viorel G. Florea, Jay N. Cohn · 2010 · Elsevier eBooks
  65. Role of Neurohormones
    Richard William Troughton, Jay Ritzema-Carter, Michael Gary Nicholls · 2008 · Elsevier eBooks
  66. Novel insights into heart failure with preserved ejection fraction
    Carolyn S.P. Lam · 2016 · University of Groningen research database (University of Groningen / Centre for Information Technology)
  67. Utilidad de los Péptidos Natriuréticos de Tipo B en la Insuficiencia Cardíaca usefulness of the Type B Natriuretic Peptides in Heart Failure
    Marcelo Valverde, Santiago Acle, Gabriela Ormaechea, Alfredo Álvarez Rocha · 2009
  68. Utility of B-Type Natriuretic Peptide in Detecting Left Ventricular Systolic Dysfunction
    Jae Won Shin, Ho‐Joong Youn, Chul Soo Park, Sang‐Hyun Ihm, Eun Ju Cho, Hae Ok Jung, Hui Kyung Jeon, Yong Seok Oh, Wook Sung Chung, Jae Hyung Kim et al. · 2003 · Journal of the Korean Society of Echocardiography
  69. Hormonal adaptation to acute and chronic hypoxia : the role of brain natriuretic peptide and stress hormones in the diagnosis and etiology of altitude illness
    Adrian J. Mellor · 2016
  70. OBSOLETE: Biomarkers: Population Screening and Risk-Stratification
    Wolfgang Lieb · 2017 · Elsevier eBooks
  71. Community detection of non-ischemic stage B heart failure
    Yang, H · 2017 · UTAS Research Repository
  72. Validation of Candidate Protein Biomarkers
    Ingibjörg Hilmarsdóttir, Nader Rifai · 2009 · Elsevier eBooks
  73. A Cross Sectional study on Diastolic Function and Factors Influencing Diastolic Function in Diabetes Mellitus Patients with Normal Systolic Function
    Subramanian Venkateswari · 2016
  74. Difference in the prevalence of subclinical left ventricular impairment among left ventricular geometric pattern in a community-based population
    Takuya Hasegawa, Masanori Asakura, Hiroshi Asanuma, Makoto Amaki, Hiroyuki Takahama, Yasuo Sugano, Hideaki Kanzaki, Satoshi Yasuda, Toshihisa Anzai, Chisato Izumi et al. · 2019 · Journal of Cardiology
  75. Estimation Of Left Ventricular Ejection Fraction Using Mitral Annular Displacement Derived By Speckle Tracking Echocardiography In Patients With Different Heart Diseases
    Mohammed Ameen Kadhim, Amal N. AL- Marayati, Ghazi F. Haji Al · 2015 · AL-Kindy College Medical Journal
  76. HİPERTİROİDİLİ HASTALARDA TEDAVİNİN BEYİN NATRİÜRETİK PEPTİD DÜZEYİNE ETKİSİ
    Zuhal Karaca Karagöz, İbrahim Şahin, Burhan Hakan Kanat, Feyzi Kurt · 2020 · Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi
  77. Heart Failure
    Elias B. Hanna · 2022 · Wiley eBooks
  78. Heart Failure
    Elias B. Hanna · 2017
  79. Disease Prevention in Heart Failure
    Viorel G. Florea, Jay N. Cohn · 2020 · Elsevier eBooks
  80. Natriuretic peptides and novel biomarkers in heart failure
    Theresa A. McDonagh · 2022
  81. Study Protocol for the Pilot Evaluation for SMartphone-adaptable Artificial Intelligence for PRediction and DeTection of Left Ventricular Systolic Dysfunction (The SMART-LV Pilot Study Protocol)
    Lovedeep Singh Dhingra, Arya Aminorroaya, Veer Sangha, Akshay Khunte, Evangelos K. Oikonomou, Bobak J. Mortazavi, Robert L. McNamara, Jeph S. Herrin, F. Perry Wilson, Harlan M. Krumholz et al. · 2023 · medRxiv
  82. Factors associated with the risk of the incidence of heart failure in diabetic patients followed in Goma, Democratic Republic of the Congo
    Ferdinand Ng’ekieb Mukoso, Aliocha Natuhoyila Nkodila, Zéphirin Tudienzela Kamuanga, Remy Yobo Kapongo, Daniel Mukad-Bamuleka, Bernard Phanzu Kianu, Hippolyte Nani Tuma Situakibanza, Benjamin Longo‐Mbenza, Stannislas Okitotsho Wembomyama, Zacharie Kibendelwa Tsongo · 2023 · Research Square
  83. AI-enabled Left Atrial Volumetry in Cardiac CT Scans Improves CHARGE-AF and Outperforms NT-ProBNP for Prediction of Atrial Fibrillation in Asymptomatic Individuals: Multi-Ethnic Study of Atherosclerosis
    Morteza Naghavi, David F. Yankelevitz, Anthony P. Reeves, Matthew Jay Budoff, Dong Li, Kyle C. Atlas, Chenyu Zhang, Thomas L. Atlas, Seth T. Lirette, Jakob Wasserthal et al. · 2024 · medRxiv
  84. Natriuretic Peptides in the Progression to Heart Failure in Hypertensive Patients
    Massimo Volpe, Speranza Donatella Rubattu · 2023 · Updates in hypertension and cardiovascular protection
  85. The Role of Serum NT-proBNP for Predicting Left Ventricular Systolic Dysfunction in Hospitalized Patients in Sri Lanka.
    B M Chaminda Rathnayake, Rasika Pawiththra Illeperuma, Sakunthala Jayasinghe, Tonks N Fawcett, Kalana Prasad Maduwage, Widana Arachchilage Thilak Ananda Jayalath, Udaya Ralapanawa · 2023 · PubMed Central
  86. Cross-Sectional Study of the Association Between Plasma Brain Natriuretic Peptide Levels and Left Ventricular Shortening Fraction in Fukuyama Congenital Muscular Dystrophy
    Takatoshi Sato, Yuki Kihara, Kumiko Ishiguro, Minobu Shichiji, Terumi Murakami, Satoru Nagata, Eriko Shimada, Kei Inai, Atsuhito Takeda, Keiko Ishigaki · 2024 · The Tohoku Journal of Experimental Medicine
  87. Addition of serum biomarkers carboxy-terminal propeptide of procollagen type I (PICP) and NT-proBNP levels to electrocardiography criteria for detection of left ventricular hypertrophyl
    Miquel Fiol, Antoni Bayés de Luna, Álvaro Alonso, Jordi Salas‐Salvadó, Estefanía Toledo, Elena Fortuny, José Francisco Forteza Albertí, Ángel M. Alonso‐Gómez, Dora Romaguera · 2025 · Elsevier eBooks
  88. 本態性高血圧症治療におけるBNP (脳性ナトリウム利尿ポリペプチド) 測定の臨床的意義
    鏑木 淳一 · 2008 · 日本未病システム学会雑誌
  89. Antecedents, characterisation and validity of cardiovascular disease biomarkers amongst South Asians in the UK
    Julia Chackathayil · 2013 · University of Birmingham Institutional Research Archive (University of Birmingham)
  90. Additional file 1 of Implications of the ACC/AHA risk score for prediction of heart failure: the Rotterdam Study
    Banafsheh Arshi, van den Berge, Jan C., Bart van Dijk, Deckers, Jaap W., M. Arfan Ikram, Kavousi, Maryam · 2021 · Figshare
  91. New biomarkers and therapeutic targets in left ventricular hypertrophy
    Maria Francesca Evaristi · 2017 · theses.fr (ABES)
  92. Biomarqueurs de la fonction ventriculaire après un infarctus du myocarde : différences hommes-femmes
    Torkia Lalem · 2018
  93. A Diagnostic Cascade Triggered by Physical Examination: Uncovering Asymptomatic Left Ventricular Dysfunction and Critical Carotid Disease in a Hypertensive Patient
    Xiuhong Lyu · 2026 · Cureus